Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Colorectal Cancer | Research article

Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network

Authors: Yang Xi, Zhuang Jing, Wu Wei, Zhang Chun, Qi Quan, Zhou Qing, Xu Jiamin, Han Shuwen

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

Sodium butyrate (NaB) is produced through the fermentation of dietary fiber that is not absorbed and digested by the small intestine.

Purpose

Here, we aimed to investigate the effects of NaB on the proliferation, invasion, and metastasis of CRC cells and their potential underlying molecular mechanism(s).

Methods

The cell counting kit-8 (CCK-8) assay and EdU assay were used to detect cell proliferation ability, flow cytometry was used to investigate the induction of apoptosis and cell cycle progression, and the scratch-wound healing and transwell assays were used to evaluate cell migration and invasion, respectively. The human CRC genome information for tissues and CRC cells treated with NaB obtained from the NCBI GEO database was reannotated and used for differential RNA analysis. Functional and pathway enrichment analyses were performed for differentially expressed lncRNAs and mRNAs. A protein-protein interaction (PPI) network for the hub genes was constructed using the Cytoscape software. Targeted miRNAs were predicted based on the lnCeDB database, and a ceRNA network was constructed using the Cytoscape software. The Kaplan-Meier method was used to analyze patient prognosis using the clinical information and exon-seq data for CRC obtained from the Broad Institute’s GDAC Firehose platform.

Results

NaB decreased the proliferation ability of CRC cells in a dose- and time-dependent manner. The number of apoptotic CRC cells increased with the increase in NaB concentrations, and NaB induced a G1 phase block in CRC cells. Moreover, NaB suppressed the migratory and invasive capabilities of CRC cells. There were 666 differentially expressed mRNAs and 30 differentially expressed lncRNAs involved in the CRC inhibition by NaB. The PPI network and ceRNA network were constructed based on the differentially expressed mRNAs and lncRNAs. Three differentially expressed mRNAs, including HMGA2, LOXL2, and ST7, were significantly correlated with the prognosis of CRC.

Conclusion

NaB induces the apoptosis and inhibition of CRC cell proliferation, invasion, and metastasis by modulating complex molecular networks. RNA prediction and molecular network construction need to be the focus of further research in this direction.
Literature
1.
go back to reference Barresi V, Reggiani Bonetti L, Ieni A, et al. Poorly differentiated clusters (PDC): clinical impact in colorectal cancer[J]. Clin Color Cancer. 2017;16(1):9-15. Barresi V, Reggiani Bonetti L, Ieni A, et al. Poorly differentiated clusters (PDC): clinical impact in colorectal cancer[J]. Clin Color Cancer. 2017;16(1):9-15.
2.
go back to reference Trowbridge B, Burt RW. Colorectal cancer screening.[J]. J Community Health. 1993;82(5):943–57. Trowbridge B, Burt RW. Colorectal cancer screening.[J]. J Community Health. 1993;82(5):943–57.
3.
go back to reference Golovko D, Kedrin D, Yilmaz ÖH, Roper J. Colorectal cancer models for novel drug discovery [J]. Expert Opin Drug Discov. 2015;10(11):1217–29.CrossRef Golovko D, Kedrin D, Yilmaz ÖH, Roper J. Colorectal cancer models for novel drug discovery [J]. Expert Opin Drug Discov. 2015;10(11):1217–29.CrossRef
4.
go back to reference Alessia B, Elena DM, Erika C, et al. Pharmacogenomics of targeted agents for personalization of colorectal Cancer treatment [J]. Int J Mol Sci. 2017;18(7):1522.CrossRef Alessia B, Elena DM, Erika C, et al. Pharmacogenomics of targeted agents for personalization of colorectal Cancer treatment [J]. Int J Mol Sci. 2017;18(7):1522.CrossRef
5.
go back to reference Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer [J]. World J Gastroenterol. 2014;20(4):943–56.CrossRef Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer [J]. World J Gastroenterol. 2014;20(4):943–56.CrossRef
6.
go back to reference Joranger P, Nesbakken A, Hoff G, et al. Modeling and validating the cost and clinical pathway of colorectal Cancer [J]. Med Decis Mak. 2015;35(2):255–65.CrossRef Joranger P, Nesbakken A, Hoff G, et al. Modeling and validating the cost and clinical pathway of colorectal Cancer [J]. Med Decis Mak. 2015;35(2):255–65.CrossRef
7.
go back to reference Kilner J, Corfe BM, Mcauley MT, et al. A deterministic oscillatory model of microtubule growth and shrinkage for differential actions of short chain fatty acids [J]. Mol BioSyst. 2016;12(1):93–101.CrossRef Kilner J, Corfe BM, Mcauley MT, et al. A deterministic oscillatory model of microtubule growth and shrinkage for differential actions of short chain fatty acids [J]. Mol BioSyst. 2016;12(1):93–101.CrossRef
8.
go back to reference Wei W, Zhibin X, Wenyi A, et al. Dietary sodium butyrate improves intestinal development and function by modulating the microbial community in broilers [J]. PLoS One. 2018;13(5):e0197762.CrossRef Wei W, Zhibin X, Wenyi A, et al. Dietary sodium butyrate improves intestinal development and function by modulating the microbial community in broilers [J]. PLoS One. 2018;13(5):e0197762.CrossRef
9.
go back to reference Sun J, Kato I. Gut microbiota, inflammation and colorectal cancer [J]. Annu Rev Microbiol. 2016;3(2):130–43. Sun J, Kato I. Gut microbiota, inflammation and colorectal cancer [J]. Annu Rev Microbiol. 2016;3(2):130–43.
10.
go back to reference Geirnaert A, Calatayud M, Grootaert C, et al. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity [J]. Sci Rep. 2017;7(1):11450.CrossRef Geirnaert A, Calatayud M, Grootaert C, et al. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity [J]. Sci Rep. 2017;7(1):11450.CrossRef
11.
go back to reference Saldanha SN, Kala R, Tollefsbol TO. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate [J]. Exp Cell Res. 2014;324(1):40–53.CrossRef Saldanha SN, Kala R, Tollefsbol TO. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate [J]. Exp Cell Res. 2014;324(1):40–53.CrossRef
12.
go back to reference Wu JT, Archer SY, Hinnebusch B, et al. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis [J]. Am J Physiol Gastrointest Liver Physiol. 2001;280(3):G48:G482–90.CrossRef Wu JT, Archer SY, Hinnebusch B, et al. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis [J]. Am J Physiol Gastrointest Liver Physiol. 2001;280(3):G48:G482–90.CrossRef
13.
go back to reference Gonçalves P, Martel F. Butyrate and colorectal Cancer: the role of butyrate transport [J]. Curr Drug Metab. 2013;14(9):994–1008.CrossRef Gonçalves P, Martel F. Butyrate and colorectal Cancer: the role of butyrate transport [J]. Curr Drug Metab. 2013;14(9):994–1008.CrossRef
14.
go back to reference Barrett T, Suzek TO, Troup DB, et al. NCBI GEO: mining millions of expression profiles—database and tools [J]. Nucleic Acids Res. 2005;33(Database Issue):D562.CrossRef Barrett T, Suzek TO, Troup DB, et al. NCBI GEO: mining millions of expression profiles—database and tools [J]. Nucleic Acids Res. 2005;33(Database Issue):D562.CrossRef
15.
go back to reference Gautier L, Cope L, Bolstad BM, et al. Affy--analysis of Affymetrix GeneChip data at the probe level [J]. Bioinformatics. 2004;20(3):307–15.CrossRef Gautier L, Cope L, Bolstad BM, et al. Affy--analysis of Affymetrix GeneChip data at the probe level [J]. Bioinformatics. 2004;20(3):307–15.CrossRef
16.
go back to reference Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for the ENCODE project [J]. Genome Res. 2012;22(9):1760–74.CrossRef Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for the ENCODE project [J]. Genome Res. 2012;22(9):1760–74.CrossRef
17.
go back to reference Jiang H, Wong WH. SeqMap: mapping massive amount of oligonucleotides to the genome [J]. Bioinformatics. 2008;24(20):2395–6.CrossRef Jiang H, Wong WH. SeqMap: mapping massive amount of oligonucleotides to the genome [J]. Bioinformatics. 2008;24(20):2395–6.CrossRef
19.
go back to reference Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons [J]. J Educ Behav Stat. 2002;27(1):77–83.CrossRef Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons [J]. J Educ Behav Stat. 2002;27(1):77–83.CrossRef
20.
go back to reference Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters [J]. OMICS. 2012;16(5):284–7.CrossRef Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters [J]. OMICS. 2012;16(5):284–7.CrossRef
21.
go back to reference Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology [J]. Gene. 2000;25(1):25–9. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology [J]. Gene. 2000;25(1):25–9.
22.
go back to reference Kanehisa M, Goto S, Kawashima S, et al. KEGG: Kyoto encyclopaedia of genes and genomes [J]. Nucleic Acids Res. 2000;28(1):27–30(4).CrossRef Kanehisa M, Goto S, Kawashima S, et al. KEGG: Kyoto encyclopaedia of genes and genomes [J]. Nucleic Acids Res. 2000;28(1):27–30(4).CrossRef
23.
go back to reference Franceschini A, Szklarczyk D, Frankild S, et al. STRING V9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration [J]. Nucleic Acids Res. 2012;41(D1):D808–15.CrossRef Franceschini A, Szklarczyk D, Frankild S, et al. STRING V9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration [J]. Nucleic Acids Res. 2012;41(D1):D808–15.CrossRef
24.
go back to reference Shannon P. Cytoscape: a software environment for integrated models of biomolecular interaction networks [J]. Genome Res. 2003;13(11):2498–504.CrossRef Shannon P. Cytoscape: a software environment for integrated models of biomolecular interaction networks [J]. Genome Res. 2003;13(11):2498–504.CrossRef
25.
go back to reference Tang Y, Li M, Wang J, et al. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks [J]. Biosystems. 2015;127:67–72.CrossRef Tang Y, Li M, Wang J, et al. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks [J]. Biosystems. 2015;127:67–72.CrossRef
26.
go back to reference Shaoli D, Suman G, Rituparno S, et al. lnCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA [J]. PLoS ONE. 2014;9(6):e98965.CrossRef Shaoli D, Suman G, Rituparno S, et al. lnCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA [J]. PLoS ONE. 2014;9(6):e98965.CrossRef
27.
go back to reference Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions [J]. Nat Methods. 2015;12(8):697.CrossRef Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions [J]. Nat Methods. 2015;12(8):697.CrossRef
28.
go back to reference Faraz B, Phillip E, Nailliw P, et al. Dietary Fiber treatment corrects the composition of gut microbiota, promotes SCFA production, and suppresses Colon carcinogenesis [J]. Genes. 2018;9(2):102.CrossRef Faraz B, Phillip E, Nailliw P, et al. Dietary Fiber treatment corrects the composition of gut microbiota, promotes SCFA production, and suppresses Colon carcinogenesis [J]. Genes. 2018;9(2):102.CrossRef
29.
go back to reference O’Keefe SJD. Diet, microorganisms and their metabolites, and colon cancer [J]. Nat Rev Gastroenterol Hepatol. 2016;13(12):691–706.CrossRef O’Keefe SJD. Diet, microorganisms and their metabolites, and colon cancer [J]. Nat Rev Gastroenterol Hepatol. 2016;13(12):691–706.CrossRef
30.
go back to reference Shuwen H, Miao D, Quan Q, et al. Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application [J]. J Cancer Res Clin Oncol. 2019;145:2169–97.CrossRef Shuwen H, Miao D, Quan Q, et al. Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application [J]. J Cancer Res Clin Oncol. 2019;145:2169–97.CrossRef
31.
go back to reference Chen HM, Yu YN, Wang JL, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma [J]. Am J Clin Nutr. 2013;97(5):1044–52.CrossRef Chen HM, Yu YN, Wang JL, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma [J]. Am J Clin Nutr. 2013;97(5):1044–52.CrossRef
32.
go back to reference Hamer H. Review article: the role of butyrate on colonic function [J]. Aliment Pyarmacol Ther. 2008;27(2):104–19.CrossRef Hamer H. Review article: the role of butyrate on colonic function [J]. Aliment Pyarmacol Ther. 2008;27(2):104–19.CrossRef
33.
go back to reference Pryde SE, Duncan SH, Hold GL, et al. The microbiology of butyrate formation in the human colon [J]. FEMS Microbiol Letters. 2002;217(2):0–139.CrossRef Pryde SE, Duncan SH, Hold GL, et al. The microbiology of butyrate formation in the human colon [J]. FEMS Microbiol Letters. 2002;217(2):0–139.CrossRef
34.
go back to reference Xu Z, Tao J, Chen P, et al. Sodium Butyrate Inhibits Colorectal Cancer Cell Migration by downregulating Bmi-1 through enhanced miR-200c expression [J]. Mol Nutr Food Res. 2018;62(6):1700844.CrossRef Xu Z, Tao J, Chen P, et al. Sodium Butyrate Inhibits Colorectal Cancer Cell Migration by downregulating Bmi-1 through enhanced miR-200c expression [J]. Mol Nutr Food Res. 2018;62(6):1700844.CrossRef
35.
go back to reference Shuwen H, Qing Z, Yan Z, et al. Competitive endogenous RNA in colorectal cancer: A systematic review [J]. Gene. 2018;645:157–62.CrossRef Shuwen H, Qing Z, Yan Z, et al. Competitive endogenous RNA in colorectal cancer: A systematic review [J]. Gene. 2018;645:157–62.CrossRef
36.
go back to reference Ling F, Du WW, Xiangling Y, et al. Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.[J]. FASEB J. 2013;27(3):907–19.CrossRef Ling F, Du WW, Xiangling Y, et al. Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.[J]. FASEB J. 2013;27(3):907–19.CrossRef
37.
go back to reference Barbagallo C, Brex D, Caponnetto A, et al. LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions [J]. Mol Ther Nucleic Acids. 2018;12:229–41.CrossRef Barbagallo C, Brex D, Caponnetto A, et al. LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions [J]. Mol Ther Nucleic Acids. 2018;12:229–41.CrossRef
38.
go back to reference Abdollahzadeh R, Daraei A, Mansoori Y, et al. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer [J]. J Cellular Physiol. 2019;234(7):10080–100.CrossRef Abdollahzadeh R, Daraei A, Mansoori Y, et al. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer [J]. J Cellular Physiol. 2019;234(7):10080–100.CrossRef
39.
go back to reference Arun K, Arunkumar G, Bennet D, et al. Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer[J]. Oncotarget. 2018;9(26):18386-99. Arun K, Arunkumar G, Bennet D, et al. Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer[J]. Oncotarget. 2018;9(26):18386-99.
40.
go back to reference Li G, Liu T, Zhang B, et al. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma[J]. J Cell Biochem. 2019;120(11):18995-9003. Li G, Liu T, Zhang B, et al. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma[J]. J Cell Biochem. 2019;120(11):18995-9003.
41.
go back to reference He F, Song Z, Chen H, et al. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128.[J]. Oncogene. 2018;38(2):164-79. He F, Song Z, Chen H, et al. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128.[J]. Oncogene. 2018;38(2):164-79.
Metadata
Title
Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network
Authors
Yang Xi
Zhuang Jing
Wu Wei
Zhang Chun
Qi Quan
Zhou Qing
Xu Jiamin
Han Shuwen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-07845-1

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine